ABSTRACT
Prospects and Opinions in Immunopathogenesis of COVID‑19
Matrix Science Medica (MSM)
Author: Letter to Editor
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
Coronavirus disease 2019 (COVID‑19) is an infectious illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with the extreme acute respiratory syndrome. CoVs are enveloped positive-sense RNA nucleic acid viruses characterized by a distinctive replication strategy; they are round and sometimes pleomorphic shapes. COVID‑19 is regarding the new genera of coronaviridae that appear the first time in Wuhan, China, in early December 2019.[1,2] At present, no specific drug or other therapeutics approved by the FDA, the number of cases due to the novel(COVID‑19) presents a serious public health problem worldwide, so deep understanding of immunopathogenesis, effective treatment methods, and more effective management strategies should be discovered as soon as possible to prevent or treat this new virus
| Pages | 59-62 |
| Year | 2021 |
| Issue | 3 |
| Volume | 5 |
